350 related articles for article (PubMed ID: 28710503)
1. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
[TBL] [Abstract][Full Text] [Related]
2. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
Henninger C; Huelsenbeck S; Wenzel P; Brand M; Huelsenbeck J; Schad A; Fritz G
Pharmacol Res; 2015 Jan; 91():47-56. PubMed ID: 25462173
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42.
Kücük P; Abbey L; Schmitt J; Henninger C; Fritz G
Pharmacol Res; 2024 May; 203():107165. PubMed ID: 38561112
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity.
Huelsenbeck J; Henninger C; Schad A; Lackner KJ; Kaina B; Fritz G
Cell Death Dis; 2011 Aug; 2(8):e190. PubMed ID: 21833028
[TBL] [Abstract][Full Text] [Related]
5. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
6. Distinct contribution of Rac1 expression in cardiomyocytes to anthracycline-induced cardiac injury.
Henninger C; Pohlmann S; Ziegler V; Ohlig J; Schmitt J; Fritz G
Biochem Pharmacol; 2019 Jun; 164():82-93. PubMed ID: 30936017
[TBL] [Abstract][Full Text] [Related]
7. The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity.
Henninger C; Huelsenbeck J; Huelsenbeck S; Grösch S; Schad A; Lackner KJ; Kaina B; Fritz G
Toxicol Appl Pharmacol; 2012 May; 261(1):66-73. PubMed ID: 22712078
[TBL] [Abstract][Full Text] [Related]
8. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.
Yoshida M; Shiojima I; Ikeda H; Komuro I
J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469
[TBL] [Abstract][Full Text] [Related]
9. Rac1 contributes to cerebral ischemia reperfusion-induced injury in mice by regulation of Notch2.
Meng S; Su Z; Liu Z; Wang N; Wang Z
Neuroscience; 2015 Oct; 306():100-14. PubMed ID: 26299339
[TBL] [Abstract][Full Text] [Related]
10. Rac1 modulates acute and subacute genotoxin-induced hepatic stress responses, fibrosis and liver aging.
Bopp A; Wartlick F; Henninger C; Kaina B; Fritz G
Cell Death Dis; 2013 Mar; 4(3):e558. PubMed ID: 23519127
[TBL] [Abstract][Full Text] [Related]
11. NSC23766, a Known Inhibitor of Tiam1-Rac1 Signaling Module, Prevents the Onset of Type 1 Diabetes in the NOD Mouse Model.
Veluthakal R; Sidarala V; Kowluru A
Cell Physiol Biochem; 2016; 39(2):760-7. PubMed ID: 27467102
[TBL] [Abstract][Full Text] [Related]
12. Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
Lenčová-Popelová O; Jansová H; Jirkovský E; Bureš J; Jirkovská-Vávrová A; Mazurová Y; Reimerová P; Vostatková L; Adamcová M; Hroch M; Pokorná Z; Kovaříková P; Šimůnek T; Štěrba M
Toxicology; 2016 Nov; 372():52-63. PubMed ID: 27816693
[TBL] [Abstract][Full Text] [Related]
13. Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.
Rea D; Coppola C; Barbieri A; Monti MG; Misso G; Palma G; Bimonte S; Zarone MR; Luciano A; Liccardo D; Maiolino P; Cittadini A; Ciliberto G; Arra C; Maurea N
In Vivo; 2016; 30(3):279-90. PubMed ID: 27107087
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1.
Willis MS; Parry TL; Brown DI; Mota RI; Huang W; Beak JY; Sola M; Zhou C; Hicks ST; Caughey MC; D'Agostino RB; Jordan J; Hundley WG; Jensen BC
Circ Heart Fail; 2019 Mar; 12(3):e005234. PubMed ID: 30871347
[TBL] [Abstract][Full Text] [Related]
15. Screening for
Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
[TBL] [Abstract][Full Text] [Related]
16. The Cardenolide Glycoside Acovenoside A Affords Protective Activity in Doxorubicin-Induced Cardiotoxicity in Mice.
Ezzat SM; El Gaafary M; El Sayed AM; Sabry OM; Ali ZY; Hafner S; Schmiech M; Jin L; Syrovets T; Simmet T
J Pharmacol Exp Ther; 2016 Aug; 358(2):262-70. PubMed ID: 27247000
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.
Antoniak S; Tatsumi K; Schmedes CM; Grover SP; Pawlinski R; Mackman N
J Mol Cell Cardiol; 2018 Sep; 122():80-87. PubMed ID: 30098988
[TBL] [Abstract][Full Text] [Related]
18. Augmented Rac1 Expression and Activity are Associated with Oxidative Stress and Decline of β Cell Function in Obesity.
Zhou S; Yu D; Ning S; Zhang H; Jiang L; He L; Li M; Sun M
Cell Physiol Biochem; 2015; 35(6):2135-48. PubMed ID: 25896148
[TBL] [Abstract][Full Text] [Related]
19. Spinochrome D Attenuates Doxorubicin-Induced Cardiomyocyte Death via Improving Glutathione Metabolism and Attenuating Oxidative Stress.
Yoon CS; Kim HK; Mishchenko NP; Vasileva EA; Fedoreyev SA; Stonik VA; Han J
Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30577438
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin protects keratinocytes from DNA damage-related pro-apoptotic stress responses stimulated by anticancer therapeutics.
Ziegler V; Albers A; Fritz G
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1082-92. PubMed ID: 26876155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
